Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Acetylcysteine and Urokinase-Type Plasminogen Activator

Research Papers that Mention the Interaction

Moreover, pre-treatment of transfected cells with N-acetyl L-cysteine blocked the silencing of uPA and uPAR, which further confirmed the oxidative damage-mediated downregulation.
International journal of oncology  •  2010  |  View Paper
Treatment with NAC , an intracellular free radical scavenger, decreased the enhancement of uPA production and tumor invasion in both cells.
Journal of experimental & clinical cancer research : CR  •  2009  |  View Paper
Pretreatment of the cells with N‐acetyl‐L‐cysteine (NAC) significantly prevented suppression of MMPs and uPA secretion, DNA binding activity of NF‐κB, and in vitro invasion of HT1080 cells by As2O3, suggesting a role of reactive oxygen species (ROS) in this process.
Journal of cellular biochemistry  •  2005  |  View Paper
Treatment of … membranes with NAC significantly suppressed lipopolysaccharide-stimulated type II phospholipase A(2) release and content; PGF(2alpha), …-6, IL-8, TNFalpha, and 8-isoprostane release; and matrix metalloproteinase-9 and urokinase-type plasminogen activator enzyme activity and suppressed NF-kappaB DNA-… activity (by ANOVA, P < 0.05).
The Journal of clinical endocrinology and metabolism  •  2003  |  View Paper
The combined incubation with reduced glutathione diethyl ester or N-acetylcysteine , antioxidants, suppressed the upregulation of uPA and uPAR mRNA and the increase in plasminogen activator activity by lysoPC.
Arteriosclerosis, thrombosis, and vascular biology  •  2000  |  View Paper